The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Dec. 19, 2013
Applicant:

Fresenius Medical Care Deutschland Gmbh, Bad Homburg, DE;

Inventors:

Ulrich Tschulena, Frankfurt am Main, DE;

Joachim Jankowski, Stahnsdorf, DE;

Anselm Fabig, Zeuthen, DE;

Carsten Mueller, Euerbach, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61M 1/34 (2006.01); A61M 1/16 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3639 (2013.01); A61M 1/16 (2013.01); A61M 1/3403 (2014.02); A61M 1/3434 (2014.02); A61M 1/361 (2014.02); A61M 1/3609 (2014.02); A61M 1/3612 (2014.02); A61M 1/3681 (2013.01); A61M 2202/0445 (2013.01); A61M 2202/0498 (2013.01); A61M 2205/054 (2013.01); A61M 2205/3344 (2013.01); A61M 2230/207 (2013.01);
Abstract

The invention relates to a device for hemodiafiltration with an extracorporeal circulation () for receiving blood to be purified and having a hemodialyzer and/or hemofilter () which is connected to the blood circulation (), such that the blood circulation () has at least one inlet line () for the supply of a replacement fluid upstream and downstream from the hemodialyzer and/or hemofilter (), characterized in that the apparatus also comprises measurement apparatuses for recording the transmembrane pressure and/or hematocrit (HKT) and/or blood density, such that the measurement apparatuses are connected to a control unit () for controlling one or more of the transmembrane pressure and/or the hematocrit (HKT) and/or the blood density, the control unit () being constructed so that the control is implemented with the help of at least one of the infusion rates (Qpre, Qpost) of the replacement fluid (), and the blood to be purified is exposed to a high-frequency electromagnetic field and/or an electric DC field () before and/or during contact with the hemodialyzer and/or hemofilter ().


Find Patent Forward Citations

Loading…